ODP644 Oral Dosing of Progestogenic Androgens for Male Contraception Show Low Serum Testosterone and High Acceptability in Placebo-Controlled Trials | Zendy

Tamar Jacobsohn | Zendy; Brian T. Nguyen | Zendy; Frances Fernando | Zendy; Jill Brown | Zendy; Diana Blithe | Zendy; Min Young Lee | Zendy; Fiona Yuen | Zendy; Ronald S. Swerdloff | Zendy; Peter Liu | Zendy; Christina Wang | Zendy; Maritza T. Farrant | Zendy; Bradley D. Anawalt | Zendy; Arthi Thirumalai | Zendy; William J. Bremner | Zendy; Stephanie T. Page | Zendy; John K. Amory | Zendy

Open Access

ODP644 Oral Dosing of Progestogenic Androgens for Male Contraception Show Low Serum Testosterone and High Acceptability in Placebo-Controlled Trials

Author(s) -

Tamar Jacobsohn,

Brian T. Nguyen,

Frances Fernando,

Jill Brown,

Diana Blithe,

Min Young Lee,

Fiona Yuen,

Ronald S. Swerdloff,

Peter Liu,

Christina Wang,

Maritza T. Farrant,

Bradley D. Anawalt,

Arthi Thirumalai,

William J. Bremner,

Stephanie T. Page,

John K. Amory

Publication year - 2022

Publication title -

journal of the endocrine society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.046

H-Index - 20

ISSN - 2472-1972

DOI - 10.1210/jendso/bvac150.1398

Subject(s) - placebo , testosterone (patch) , prodrug , tolerability , dosing , medicine , male contraceptive , dose , endocrinology , pharmacology , androgen , drug , hormone , population , adverse effect , family planning , alternative medicine , environmental health , pathology , research methodology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research